secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcutis Biotherapeutics, Inc. (ARQT)
CIK:        0001787306
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001628280-24-008496
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcutis raises ~$161.6M in public offering of 18.2M shares at $9.50
-------------------------------------------------------------------

- Issued ~18.2M shares at $9.50 via underwritten public offering, raising ~$161.6M net.
- Underwriters fully exercised 30-day option to purchase additional 2,368,421 shares on Feb 29, 2024.
- Net proceeds intended to fund commercialization, development, and approval for atopic dermatitis, scalp psoriasis, and psoriasis expansion.
- Offering conducted under existing Form S-3 shelf registration (File No. 333-276794).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/0001628280-24-008496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/arqt-20240228.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-008496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer